Selective serotonin reuptake inhibitor: Difference between revisions
>Brack sedation & stimulation |
>Brack effects |
||
Line 16: | Line 16: | ||
{{effects/base | {{effects/base | ||
|{{effects/physical| | |{{effects/physical| | ||
*'''[[Effect::Orgasm suppression]]''' - | *'''[[Effect::Orgasm suppression]]''' - This effect is usually is mild and only delays orgasms, however in some people, particularly older users, SSRIs can make one completely unable to reach orgasm. This is usually treated by either switching to a different antidepressant, or adding a DNRI such as [[bupropion]]. | ||
*'''[[Effect::Physical fatigue]]''' | *'''[[Effect::Physical fatigue]]''' | ||
*'''[[Effect::Sedation]]''' or '''[[Effect::Stimulation]]''' - | *'''[[Effect::Sedation]]''' or '''[[Effect::Stimulation]]''' - Most SSRIs are sedating while others can be mildly stimulating. The sedation produced by SSRIs is usually very mild during the day, but very intense at night. This can make one unable to stay awake at night, however is usually considered a positive effect by most people, as depression often is accompanied by insomnia. | ||
*'''[[Effect::Nausea]]''' - Nausea is mild and is usually only present upon first introduction and usually subsides after 4-8 weeks. | |||
*'''[[Effect::Headaches]]''' - Headaches are usually only present upon first introduction and usually subside after 4-8 weeks | |||
}} | }} | ||
{{Template talk:effects/withdrawal| | {{Template talk:effects/withdrawal| | ||
Line 39: | Line 41: | ||
*'''[[Effect::Dream potentiation]]''' | *'''[[Effect::Dream potentiation]]''' | ||
*'''[[Effect::Ego inflation]]''' | *'''[[Effect::Ego inflation]]''' | ||
*'''[[Effect::Emotion suppression]]''' | *'''[[Effect::Emotion suppression]]''' - This effect is similar to but less intense compared to the [[emotion supression]] induced by antipsychotics. | ||
*'''[[Effect::Mania]]''' | *'''[[Effect::Mania]]''' | ||
*'''[[Effect::Suicidal ideation]] | *'''[[Effect::Suicidal ideation]]''' <ref>Björkenstam, C., Möller, J., Gunilla Ringbäck, G., Salmi, P., Hallgvist, J., & Ljung, R. (2013, September 9). An Association between Initiation of Selective Serotonin Reuptake Inhibitors and Suicide - A Nationwide Register-Based Case-Crossover Study. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767591/</ref> - Upon first introduction, some users (especially children) can experience increase suicidal and self harming thoughts and behaviors. This effect usually subsides within 4-8 weeks. | ||
}} | }} | ||
{{effects/paradoxical| | {{effects/paradoxical| |